| T: primary tumor | | | | | | | |
| TX | Primary tumor cannot be assessed | | | | | | |
| T0 | No evidence of primary tumor | | | | | | |
| Tis | Carcinoma in situ | | | | | | |
| T1a | Tumor 5 mm or less in greatest dimension | | | | | | |
| T1b | Tumor greater than 5 mm and less than 1 cm in greatest dimension | | | | | | |
| T1c | Tumor greater than 1 cm but no more than 2 cm in greatest dimension | | | | | | |
| T2 | Tumor more than 2 cm but no more than 4 cm in greatest dimension | | | | | | |
| T3 | Tumor and more than 4 cm in greatest dimension | | | | | | |
| T4 | Tumor involves celiac axis, superior mesenteric artery or common hepatic artery | | | | | | |
| N: regional lymph nodes | | | | | | | |
| NX | Regional lymph nodes cannot be assessed | | | | | | |
| N0 | No regional lymph node metastasis | | | | | | |
| N1 | Metastasis in 1?3 regional lymph nodes | | | | | | |
| N2 | Metastasis in 4 or more regional lymph nodes | | | | | | |
| M: distant metastasis | | | | | | | |
| M0 | No distant metastasis | | | | | | |
| M1 | Distant metastasis | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |